Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension
This study is currently recruiting patients.
Sponsored by: | Alcon Research |
---|---|
Information provided by: | Alcon Research |
Purpose
To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
Condition | Treatment or Intervention | Phase |
---|---|---|
Glaucoma, Open-Angle Ocular Hypertension |
Drug: Combination IOP Lowering Therapy |
Phase II |
MedlinePlus related topics: Eye Diseases; Glaucoma
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A 6-week safety and efficacy study of combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Location and Contact Information
More Information
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |